Cardiomyopathy in patients with biallelic JUP mutations, characterized by fibrofatty replacement of myocardium with subsequent ventricular dilatation and systolic dysfunction, carries a poor prognosis due to increased risk of ventricular arrhythmias and sudden cardiac death although the patients are often asymptomatic at an early age. The gene discussed is JUP; the disease is cardiomyopathy.